CStone Pharmaceuticals (2616.HK) Q1 2024 Earnings

Mar 27Confirmed
Q1 2024
-0.14
-0.13
-0.12
-0.11

Details

Expected EPS
-0.110195406
Actual EPS
-0.1432540278
Surprise EPS
-0.03
Surprise Percent
-30%

Description

⁨CStone Pharmaceuticals⁩ (⁦2616.HK⁩) has reported earnings of ⁦-0.1432540278⁩ per share for ⁦Q1 2024⁩.

0 Comments

Share your thoughts